Replimune Group, Inc. REPL
12.36
(0.24)
(1.90%)
as of 25 Sep
- Market cap
- $1.2B
- P/E
- 0.0×
Follow REPL
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
5.23 | 4.79 | 5.60 | 6.31 |
+8 more quarters Free account |
Net Debt/EBITDA |
1.34 | 2.25 | 2.80 | 2.99 | |
Debt/Assets |
41.91% | 31.65% | 20.91% | 17.86% | |
Debt/Equity |
1.00 | 0.63 | 0.33 | 0.26 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.09 | 0.77 | 0.93 | 0.98 | |
Capex/Depreciation |
0.00 | (0.01) | (0.19) | 1.89 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.78) | (0.61) | (0.72) | (0.90) | |
Cash per Share |
2.02 | 2.90 | 2.92 | 3.52 | |
Shareholders Equity per Share |
1.09 | 1.79 | 2.28 | 2.87 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.09 | 1.79 | 2.28 | 2.87 | |
Free Cash Flow |
(75.73) | (56.17) | (66.09) | (82.55) | |
Working Capital |
162.40 | 220.89 | 230.27 | 280.85 | |
Capital Expenditures |
(0.01) | 0.00 | (0.13) | (1.34) | |
Net Current Asset Value |
54.01 | 112.89 | 157.30 | 207.64 | |
| Other line items | |||||
Quick Ratio |
5.09 | 4.65 | 5.43 | 6.15 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.78) | (0.61) | (0.72) | (0.88) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Average Receivables |
— | 2.67 | 3.01 | 1.93 | |
Average Payables |
9.87 | 9.57 | 6.42 | 7.41 | |
Average Assets |
360.98 | 441.86 | 468.61 | 443.83 | |
Average Common Equity |
221.18 | 291.00 | 346.46 | 322.40 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates